В. Е. Парфенов

572 total citations
18 papers, 404 citations indexed

About

В. Е. Парфенов is a scholar working on Genetics, Cancer Research and Surgery. According to data from OpenAlex, В. Е. Парфенов has authored 18 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 6 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in В. Е. Парфенов's work include Glioma Diagnosis and Treatment (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and TGF-β signaling in diseases (4 papers). В. Е. Парфенов is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer, Hypoxia, and Metabolism (6 papers) and TGF-β signaling in diseases (4 papers). В. Е. Парфенов collaborates with scholars based in Germany, Russia and India. В. Е. Парфенов's co-authors include K.-H. Schlingensiepen, Ulrich Bogdahn, H. Heinrichs, Peter Hau, N. K. Venkataramana, Günther Stockhammer, Anuspandana Mahapatra, Piotr Jachimczak, Menashe Zaaroor and Anandh Balasubramaniam and has published in prestigious journals such as Journal of Clinical Oncology, Neuro-Oncology and Drug Development Research.

In The Last Decade

В. Е. Парфенов

17 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
В. Е. Парфенов Germany	7	200	175	163	67	64	18	404
S. Schmaus Germany	6	234 1.2×	240 1.4×	144 0.9×	79 1.2×	80 1.3×	10	449
Anuspandana Mahapatra India	7	195 1.0×	167 1.0×	163 1.0×	63 0.9×	61 1.0×	19	407
Sarah Gaffey United States	9	152 0.8×	148 0.8×	243 1.5×	71 1.1×	87 1.4×	22	402
P. Y. Wen United States	5	194 1.0×	182 1.0×	324 2.0×	81 1.2×	138 2.2×	5	506
Takrima Haque Canada	7	224 1.1×	105 0.6×	175 1.1×	37 0.6×	82 1.3×	12	396
A. S. United States	6	193 1.0×	114 0.7×	186 1.1×	121 1.8×	72 1.1×	7	425
Astrid De Boeck Belgium	8	219 1.1×	311 1.8×	109 0.7×	81 1.2×	148 2.3×	10	549
Yukina Morimoto Japan	14	125 0.6×	126 0.7×	196 1.2×	114 1.7×	47 0.7×	33	483
Raphaêl Lis United States	9	213 1.1×	207 1.2×	101 0.6×	65 1.0×	168 2.6×	10	448
Luis R. Borlado Spain	9	376 1.9×	105 0.6×	95 0.6×	97 1.4×	66 1.0×	11	529

Countries citing papers authored by В. Е. Парфенов

Since Specialization

Citations

This map shows the geographic impact of В. Е. Парфенов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. Е. Парфенов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. Е. Парфенов more than expected).

Fields of papers citing papers by В. Е. Парфенов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. Е. Парфенов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. Е. Парфенов. The network helps show where В. Е. Парфенов may publish in the future.

Co-authorship network of co-authors of В. Е. Парфенов

This figure shows the co-authorship network connecting the top 25 collaborators of В. Е. Парфенов. A scholar is included among the top collaborators of В. Е. Парфенов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. Е. Парфенов. В. Е. Парфенов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Парфенов, В. Е., et al.. (2022). Professor Anatoly Alekseevich Kurygin (1932-2011) (to the 90th anniversary of the birth of A.A. Kurygin). 8–12.

Парфенов, В. Е., et al.. (2019). A multidisciplinary approach to skin plastic of skull defects formed after implantation. 21(3). 58–65. 1 indexed citations

Парфенов, В. Е., et al.. (2018). Stereotactic Cryodestruction of Gliomas. Progress in neurological surgery. 32. 27–38. 12 indexed citations

Крылов, В. В., et al.. (2015). An advisory protocol for treatment of acute complicated and uncomplicated spinal cord injury in adults (association of neurosurgeons of the Russian Federation). Part 3. Burdenko s Journal of Neurosurgery. 79(2). 97–97. 7 indexed citations

Крылов, В. В., et al.. (2015). Recommended protocol for treating complicated and uncomplicated acute spinal injury in adults (Association of Neurosurgeons of Russia). Part 2. Burdenko s Journal of Neurosurgery. 79(1). 83–83. 5 indexed citations

Крылов, В. В., et al.. (2014). A protocol recommended for treating acute complicated and uncomplicated spinal injuries in adult patients (Association of Neurosurgeons of Russia). Part 1. Burdenko s Journal of Neurosurgery. 78(6). 60–60. 5 indexed citations

Bogdahn, Ulrich, Peter Hau, Günther Stockhammer, et al.. (2010). Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-Oncology. 13(1). 132–142. 331 indexed citations

Bogdahn, Ulrich, Guenther Stockhammer, Anuspandana Mahapatra, et al.. (2010). Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients.. Journal of Clinical Oncology. 28(15_suppl). 2054–2054. 1 indexed citations

Bogdahn, Ulrich, В. Е. Парфенов, Ashok Kumar Mahapatra, et al.. (2009). Randomized, active-controlled phase IIb study with trabedersen (AP 12009) in recurrent or refractory high-grade glioma patients: Basis for phase III endpoints. Journal of Clinical Oncology. 27(15_suppl). 2037–2037. 6 indexed citations

10.

Bogdahn, Ulrich, Peter Hau, Anuspandana Mahapatra, et al.. (2008). Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase Iib study. Journal of Clinical Oncology. 26(15_suppl). 2018–2018. 6 indexed citations

11.

Bogdahn, Ulrich, Anuspandana Mahapatra, В. Е. Парфенов, et al.. (2008). Results of a phase Iib active-controlled study with AP 12009 for patients with recurrent or refractory anaplastic astrocytoma. Journal of Clinical Oncology. 26(15_suppl). 2076–2076. 6 indexed citations

12.

Hau, Peter, Ulrich Bogdahn, Ashok Kumar Mahapatra, et al.. (2007). Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009. Journal of Clinical Oncology. 25(18_suppl). 12521–12521. 6 indexed citations

13.

Bogdahn, Ulrich, Ashok Kumar Mahapatra, В. Е. Парфенов, et al.. (2007). A phase IIb actively controlled study with the TGF-beta-2 inhibitor AP 12009 for recurrent or refractory anaplastic astrocytoma. Journal of Clinical Oncology. 25(18_suppl). 2025–2025. 1 indexed citations

14.

Bogdahn, Ulrich, В. Е. Парфенов, M. Kunst, et al.. (2006). Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009. Journal of Clinical Oncology. 24(18_suppl). 1553–1553. 5 indexed citations

15.

Hau, Peter, Günther Stockhammer, M. Kunst, et al.. (2006). Results of G004, a phase IIb actively controlled clinical trial with the TGF-b2 targeted compound AP 12009 for recurrent anaplastic astrocytoma. Journal of Clinical Oncology. 24(18_suppl). 1566–1566. 5 indexed citations

16.

Hau, Peter, M. Kunst, Josef Pichler, et al.. (2005). Targeted downregulation of TGF-beta2 as immunotherapy for high-grade glioma: A phase IIb study. Journal of Clinical Oncology. 23(16_suppl). 1537–1537. 3 indexed citations

17.

Парфенов, В. Е., et al.. (1998). [The combined use of intraoperative video endoscopy and contact microvascular dopplerography in the surgery of cerebral aneurysms].. PubMed. 157(5). 133–7. 3 indexed citations

18.

Парфенов, В. Е., et al.. (1988). Pharmacologic corrections of cerebral blood flow and CO₂‐reactivity in cerebrovascular insufficiency. Drug Development Research. 14(3-4). 223–225. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact